BriaCell Therapeutics Statistics

Total Valuation

TSX:BCT has a market cap or net worth of CAD 40.02 million. The enterprise value is -1.49 million.

Market Cap	40.02M
Enterprise Value	-1.49M

Important Dates

The next estimated earnings date is Friday, June 5, 2026.

Earnings Date	Jun 5, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:BCT has 7.25 million shares outstanding. The number of shares has increased by 784.70% in one year.

Current Share Class	7.25M
Shares Outstanding	7.25M
Shares Change (YoY)	+784.70%
Shares Change (QoQ)	+48.75%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	3.29%
Float	6.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.98
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.10

Current Ratio	10.10
Quick Ratio	9.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-831.19

Financial Efficiency

Return on equity (ROE) is -179.21% and return on invested capital (ROIC) is -114.89%.

Return on Equity (ROE)	-179.21%
Return on Assets (ROA)	-89.44%
Return on Invested Capital (ROIC)	-114.89%
Return on Capital Employed (ROCE)	-101.08%
Weighted Average Cost of Capital (WACC)	13.19%
Revenue Per Employee	n/a
Profits Per Employee	-2.51M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.40% in the last 52 weeks. The beta is 1.63, so TSX:BCT's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	-92.40%
50-Day Moving Average	5.64
200-Day Moving Average	10.48
Relative Strength Index (RSI)	46.44
Average Volume (20 Days)	17,526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.69M
Pretax Income	-40.64M
Net Income	-40.20M
EBITDA	-41.55M
EBIT	-41.69M
Earnings Per Share (EPS)	-27.10

Full Income Statement

Balance Sheet

The company has 40.56 million in cash and n/a in debt, giving a net cash position of 40.56 million or 5.59 per share.

Cash & Cash Equivalents	40.56M
Total Debt	n/a
Net Cash	40.56M
Net Cash Per Share	5.59
Equity (Book Value)	40.98M
Book Value Per Share	5.78
Working Capital	39.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-42.00M
Capital Expenditures	n/a
Depreciation & Amortization	145,877
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:BCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-784.70%
Shareholder Yield	-784.70%
Earnings Yield	-100.45%
FCF Yield	n/a

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1